The relationship between bone morphogenic protein-7 and peritoneal transport characteristics

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2989-2994

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Kwan, Bonnie Ching Ha ^a   Lai, Ka Bik ^a   Chung, Kwok Yi ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Growth factor; Renal failure; Ultrafiltration

Indexed keywords

C REACTIVE PROTEIN; CREATININE; MESSENGER RNA; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIALYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

AGED; BONE MORPHOGENETIC PROTEIN 7; C-REACTIVE PROTEIN; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; TRANSFORMING GROWTH FACTOR BETA; ULTRAFILTRATION;

EID: 58549103716     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn188     Document Type: Article

References (34)

1. Szeto CC, Wong TY, Leung CB et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000; 58: 400-407
2. Kawaguchi Y, Hasegawa T, Nakayama M et al. Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int Suppl 1997; 62: S105-S107
3. Nagy J. Peritoneal membrane morphology and function. Kidney Int 1996; 50: S2-S11
4. Yanez-Mo M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413
5. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
6. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784
7. Neilson EG. Setting a trap for tissue fibrosis. Nat Med 2005; 11: 373-374
8. Wong TY, Phillips AO, Witowski J et al. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63: 1404-1416
9. Perfumo F, Altieri P, Degl'Innocenti ML et al. Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation. Nephrol Dial Transplant 1996; 11: 1803-1809
10. Saed GM, Zhang W, Chegini N et al. Alteration of type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta1. Wound Repair Regen 1999; 7: 504-510
11. Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int 2003; 63: 1530-1539
12. Vargha R, Endemann M, Kratochwill K et al. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 2006; 21: 2943-2947
13. Aroeira LS, Aguilera A, Sanchez-Tomero JA et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007; 18: 2004-2013
14. Beddhu S, Zeidel ML, Saul M et al. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med 2002; 112: 696-701
15. Stenvinkel P, Chung SH, Heimburger O et al. Malnutrition, inflammation and atherosclerosis in peritoneal dialysis patients. Perit Dial Int 2001; 21(Suppl 3): S157-162
16. Sezer S, Elsurer R, Afsar B et al. Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients. Nephron Clin Pract 2007; 107: c156-162
17. Szeto CC, Wong TY, Chow KM et al. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients - a randomized placebo-control trial. J Am Soc Nephrol 2003; 14: 2119-2126
18. Wong TY, Szeto CC, Chow KM et al. Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis. Am J Kidney Dis 2005; 46: 713-719
19. Twardowski ZJ, Nolph KD, Prowant B et al. Peritoneal equilibration test. Peritoneal Dial Bull 1987; 7: 138-147
20. Mak TW, Cheung CK, Cheung CM et al. Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol Dial Transplant 1997; 12: 184-186
21. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ et al. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif 1986; 4: 194-203
22. Noe DA. A body surface area nomogram based on the formula of Gehan and George. J Pharm Sci 1991; 80: 501
23. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J of Med 2001; 344: 947-954
24. Szeto CC, Lai KB, Chow KM et al. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients. J Nephrol 2005; 18: 197-203
25. Lo WK, Brendolan A, Prowant BF et al. Changes in the peritoneal equilibration test in selected chronic peritoneal dialysis patients. J Am Soc Nephrol 1994; 4: 1466-1474
26. Raj DS, Langos V, Gangam N et al. Ethnic variability in peritoneal equilibration test and urea kinetics. Am J Kidney Dis 1997; 30: 374-381
27. Wong TY, Szeto CC, Lai KB et al. Longitudinal study of peritoneal membrane function in CAPD: relationship with peritonitis and fibrosing factors. Perit Dial Int 2000; 20: 679-686
28. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 2005; 280: 8094-8100
29. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGFbeta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968
30. Szeto CC, Law MC, Wong TY et al. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients - a two-year prospective study. Am J Kidney Dis 2001; 37: 329-336
31. Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006; 17: 271-278
32. Brimble KS, Walker M, Margetts PJ et al. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2591-2598
33. Lai KN, Lai KB, Szeto CC et al. Growth factors in continuous ambulatory peritoneal dialysis effluent - their relation with peritoneal transport of small solutes. Am J Nephrol 1999; 19: 416-422
34. Klahr S. The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function. J Nephrol 2003; 16: 179-185